Holen Sie sich die Stockscreener-App
91.85
1.87%
-1.75
Handel nachbörslich:
91.53
-0.32
-0.35%
Disc Medicine Inc Aktie (IRON) Neueste Nachrichten
Frazier Life Sciences Management L.P. Has $87.64 Million Holdings in Disc Medicine, Inc. $IRON - MarketBeat
This is why Disc Medicine, Inc. (IRON) is a buy on Wall Street - MSN
All You Need to Know About Disc Medicine, Inc. (IRON) Rating Upgrade to Buy - MSN
Eventide Asset Management LLC Buys 126,212 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. $IRON Position Lowered by Bain Capital Life Sciences Investors LLC - MarketBeat
Has Disc Medicine’s 2025 Surge Already Gone Too Far After Pipeline Progress Fuels Rally? - Yahoo Finance
Leering Partners Lifts Disc Medicine, Inc. (IRON) Following EPP Drug NDA Application - MSN
Discipline and Rules-Based Execution in IRON Response - news.stocktradersdaily.com
Disc Medicine (IRON): Reassessing Valuation After Encouraging RALLY-MF Phase 2 Anemia Data - simplywall.st
H.C. Wainwright reiterates Buy rating on Disc Medicine stock By Investing.com - Investing.com Canada
This is Why Disc Medicine, Inc. (IRON) is a Buy on Wall Street - Finviz
Disc Medicine stock price target raised to $115 by Leerink on MF anemia data - Investing.com Canada
Disc Medicine (NASDAQ:IRON) Sets New 12-Month HighTime to Buy? - MarketBeat
Disc Medicine Inc stock hits 52-week high at 97.63 USD - Investing.com Nigeria
ASH: Disc Set for Busy 2026 After Promising Interim Anemia Drug Data - Citeline News & Insights
Disc Medicine stock price target raised to $117 by Raymond James on trial data - Investing.com UK
Disc Medicine Advances Bitopertin in FDA Pilot Program - TipRanks
Disc Medicine, Inc. Reviews ASH Meeting Data and Operational Plans - TradingView — Track All Markets
Disc Medicine (NASDAQ:IRON) Builds Momentum In Clinical Science - Kalkine Media
IRON Stock Boosted by Positive Phase 2 Trial Results of DISC-097 - GuruFocus
Transcript : Disc Medicine, Inc.Special Call - marketscreener.com
Bollard Group LLC Takes Position in Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine reveals encouraging Phase 2 data at ASH event - Traders Union
Disc Medicine reports positive data from DISC-0974 anemia trial By Investing.com - Investing.com Canada
Disc Medicine reports positive data from DISC-0974 anemia trial - Investing.com
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting - The Manila Times
Disc Medicine Presents Positive Initial Data from RALLY-MF - GlobeNewswire
IRONAI Stock Analysis - Meyka
Saturn V Capital Management LP Sells 122,062 Shares of Disc Medicine, Inc. $IRON - MarketBeat
How Disc Medicine Inc. stock trades before earningsMarket Performance Summary & Consistent Growth Stock Picks - Newser
Disc Medicine Earnings Notes - Trefis
Certain Stock Options of Disc Medicine, Inc. are subject to a Lock-Up Agreement Ending on 5-DEC-2025. - marketscreener.com
Certain Pre-Funded Warrants of Disc Medicine, Inc. are subject to a Lock-Up Agreement Ending on 5-DEC-2025. - marketscreener.com
Disc Medicine, Inc. $IRON Shares Acquired by Sio Capital Management LLC - MarketBeat
Is Disc Medicine Inc. stock positioned well for digital economy2025 Institutional Moves & Growth Focused Stock Pick Reports - Newser
Disc Medicine (IRON) Stock Analysis Report | Financials & Insights - Benzinga
JPMorgan Chase & Co. Grows Position in Disc Medicine, Inc. $IRON - MarketBeat
Analysis Recap: How Disc Medicine Inc stock trades before earnings2025 EndofYear Setup & Free Verified High Yield Trade Plans - BỘ NỘI VỤ
Disc Medicine announces public offering of common stock and pre-funded warrants - MSN
Geode Capital Management LLC Purchases 26,605 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Behavioral Patterns of IRON and Institutional Flows - news.stocktradersdaily.com
DNB Asset Management AS Takes $243,000 Position in Disc Medicine, Inc. $IRON - MarketBeat
Is Disc Medicine Inc. stock attractive for hedge fundsRecession Risk & Expert Curated Trade Ideas - BỘ NỘI VỤ
Portfolio Adjustment: Institutional Heavyweight Exits Biotech Stock - AOL.com
Ensign Peak Advisors Inc Purchases 69,032 Shares of Disc Medicine, Inc. $IRON - MarketBeat
Disc Medicine, Inc. (NASDAQ:IRON) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Disc Medicine stock hits 52-week high at 96.09 USD By Investing.com - Investing.com Nigeria
Disc Medicine stock hits 52-week high at 96.09 USD - Investing.com
FY2025 EPS Estimate for Disc Medicine Decreased by Analyst - MarketBeat
Disc Medicine Inc. (IRON) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
How Disc Medicine Inc. stock performs in high volatility marketsGap Up & Free Fast Entry Momentum Trade Alerts - newser.com
1.08%
0.91%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):